DWP
PFE icon

Destiny Wealth Partners’s Pfizer PFE Stock Holding History

Destiny Wealth Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,209
Closed -$118K – 829
2026
Q1 		$118K Buy
+4,209
New +$112K 0.01% 309
2023
Q1 		– Sell
-5,252
Closed -$269K – 503
2022
Q4 		$269K Buy
5,252
+414
+9% +$19.8K 0.06% 166
2022
Q3 		$212K Buy
4,838
+2,119
+78% +$103K 0.05% 177
2022
Q2 		$143K Sell
2,719
-139
-5% -$7.08K 0.03% 211
2022
Q1 		$148K Buy
2,858
+32
+1% +$1.66K 0.03% 185
2021
Q4 		$167K Buy
2,826
+54
+2% +$2.67K 0.03% 196
2021
Q3 		$119K Sell
2,772
-6,396
-70% -$283K 0.02% 203
2021
Q2 		$359K Buy
9,168
+6,285
+218% +$244K 0.07% 148
2021
Q1 		$104K Buy
2,883
+52
+2% +$1.85K 0.02% 205
2020
Q4 		$104K Buy
+2,831
New +$104K 0.02% 237

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Destiny Wealth Partners's PFE Position: Q2 2026 in Review

Destiny Wealth Partners sold out of Pfizer (PFE) in Q2 2026, closing a stake of 4,209 shares — an estimated $118K sold.

Destiny Wealth Partners first reported a position in PFE in Q4 2020 and held it in 10 quarters. The position peaked at $359K in Q2 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Destiny Wealth Partners reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 4,209 Pfizer shares in Q2 2026, an estimated $118K.
  • Destiny Wealth Partners first reported a position in Pfizer in Q4 2020 and held it in 10 quarters.
  • Destiny Wealth Partners's Pfizer position peaked at $359K in Q2 2021.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.